Unknown

Dataset Information

0

A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity.


ABSTRACT: Folate receptor beta (FR?) is only detectable in placenta and limited to some hematopoietic cells of myeloid lineage in healthy people. Studies have indicated that FR? is over-expressed in activated macrophages in autoimmune diseases and some cancer cells. In this study we aimed to develop an FR?-specific human monoclonal antibody (mAb) that could be used as a therapeutic agent to treat rheumatoid arthritis and other autoimmune diseases, as well as FR? positive cancers.Functional recombinant FR? protein was produced in insect cells and used as antigen to isolate a mAb, m909, from a human naïve Fab phage display library. Binding of Fab and IgG1 m909 to FR? was measured by ELISA, surface plasmon resonance, immune fluorescence staining, and flow cytometry. Antibody-dependent cell-mediated cytotoxicity (ADCC) was evaluated with FR? positive CHO cells as target cells and isolated peripheral blood monocytes as effector cells in an in vitro assay.Fab m909 bound with relatively high affinity (equilibrium dissociation constant 57 nM) to FR?. The IgG1 m909 showed much higher (femtomolar) avidity as measured by ELISA, and it bound to FR? positive cells in a dose-dependent manner, but not to parental FR? negative cells. m909 did not compete with folate for the binding to FR? on cells. m909 was not only able to select FR? positive, activated macrophages from synovial fluid cells of arthritis patients as efficiently as folate, but also able to mediate ADCC in FR? positive cells.Unlike folate-drug conjugates, m909 selectively binds to FR?, does not recognize FR?, and has at least one effector function. m909 alone has potential to eliminate FR? positive cells. Because m909 does not compete with folate for receptor binding, it can be used with folate-drug conjugates in a combination therapy. m909 can also be a valuable research reagent.

SUBMITTER: Feng Y 

PROVIDER: S-EPMC3132054 | biostudies-literature | 2011 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity.

Feng Yang Y   Shen Jiayin J   Streaker Emily D ED   Lockwood Michael M   Zhu Zhongyu Z   Low Philip S PS   Dimitrov Dimiter S DS  

Arthritis research & therapy 20110408 2


<h4>Introduction</h4>Folate receptor beta (FRβ) is only detectable in placenta and limited to some hematopoietic cells of myeloid lineage in healthy people. Studies have indicated that FRβ is over-expressed in activated macrophages in autoimmune diseases and some cancer cells. In this study we aimed to develop an FRβ-specific human monoclonal antibody (mAb) that could be used as a therapeutic agent to treat rheumatoid arthritis and other autoimmune diseases, as well as FRβ positive cancers.<h4>M  ...[more]

Similar Datasets

| S-EPMC6555977 | biostudies-literature
| S-EPMC3346070 | biostudies-literature
| S-EPMC3126567 | biostudies-literature
| S-EPMC4118152 | biostudies-other
| S-EPMC6211298 | biostudies-other
| S-EPMC6006506 | biostudies-literature
| S-EPMC9550058 | biostudies-literature
| S-EPMC1351261 | biostudies-literature
| S-EPMC8656063 | biostudies-literature
| S-EPMC6251304 | biostudies-literature